These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 13614427)

  • 1. Myasthenia gravis. III. Lack of inhibitory action of fractionated thymus extracts.
    ZACKS SI
    Proc Soc Exp Biol Med; 1958 Dec; 99(3):574-5. PubMed ID: 13614427
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromuscular transmission in myasthenia gravis.
    CHURCHILL-DAVIDSON HC; RICHARDSON AT
    J Physiol; 1953 Nov; 122(2):252-63. PubMed ID: 13118536
    [No Abstract]   [Full Text] [Related]  

  • 3. Some effects of extracts of thymus glands removed from patients with myasthenia gravis.
    WILSON A; OBRIST AR; WILSON H
    Lancet; 1953 Aug; 265(6782):368-71. PubMed ID: 13085784
    [No Abstract]   [Full Text] [Related]  

  • 4. An electrophysiologic study of the neuromuscular junction in myasthenia gravis.
    DAHLBACK O; ELMQVIST D; JOHNS TR; RADNER S; THESLEFF S
    J Physiol; 1961 Apr; 156(2):336-43. PubMed ID: 13719322
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis.
    Namba T; Nakata Y; Grob D
    Ann N Y Acad Sci; 1976; 274():493-515. PubMed ID: 786115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies in neuromuscular function. II. Effects of nerve stimulation in normal subjects and in patients with myasthenia gravis.
    GROB D; HARVEY AM; JOHNS RJ
    Bull Johns Hopkins Hosp; 1956 Sep; 99(3):125-35. PubMed ID: 13364528
    [No Abstract]   [Full Text] [Related]  

  • 7. Myasthenia gravis. I. Importance of potassium in inhibitory action of normal and myasthenic thymus extracts.
    ZACKS SI; COHEN RB
    Proc Soc Exp Biol Med; 1955 Dec; 90(3):601-6. PubMed ID: 13289849
    [No Abstract]   [Full Text] [Related]  

  • 8. Motor end plate changes in myasthenia gravis.
    CHURCHILL-DAVIDSON HC
    Am J Phys Med; 1959 Aug; 38():159-62. PubMed ID: 13810230
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of thymic extract on the neuromuscular junction.
    Parkes JD; McKinna JA
    Nature; 1967 Jun; 214(5093):1116-7. PubMed ID: 6053071
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuromuscular transmission with a note on myasthenia gravis.
    MEAD JC
    McGill Med J; 1957 Apr; 26(2):88-95. PubMed ID: 13429923
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathogenic investigations on myasthenia and myotonia with special reference to therapy. II. Effect of blood serum isolated in myotonia on nerve-muscle preparation in frog].
    KURES H; MALEK P
    Cas Lek Cesk; 1952 Jun; 91(24-25):709-11. PubMed ID: 14390261
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the reaction of the isolated phrenic nerve diaphragm preparation of various species to certain agents causing a neuromuscular block.
    BERGH NP
    Scand J Clin Lab Invest; 1953; 5 Suppl 7():5-29. PubMed ID: 13075957
    [No Abstract]   [Full Text] [Related]  

  • 13. Observations on the nature of the neuromuscular block in myasthenia gravis.
    HARVEY AM; GROB D; JOHNS RJ
    Trans Assoc Am Physicians; 1954; 67():94-6. PubMed ID: 13216816
    [No Abstract]   [Full Text] [Related]  

  • 14. The thymus and neuromuscular function. A substance in thymus which causes myositis and myasthenic neuromuscular block in guineapigs.
    Goldstein G
    Lancet; 1968 Jul; 2(7560):119-22. PubMed ID: 4173256
    [No Abstract]   [Full Text] [Related]  

  • 15. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis.
    NASTUK WL; STRAUSS AJ; OSSERMAN KE
    Am J Med; 1959 Mar; 26(3):394-409. PubMed ID: 13626994
    [No Abstract]   [Full Text] [Related]  

  • 17. [Severity of myasthenia gravis is related to the degree of neuromuscular blocking effect by isoflurane].
    Kadosaki M; Enzan K; Horiguchi T; Komatsu H; Suzuki M
    Masui; 1993 Jun; 42(6):906-9. PubMed ID: 8320811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of calcium antagonist drugs in myasthenia gravis in the elderly.
    Pina Latorre MA; Cobeta JC; Rodilla F; Navarro N; Zabala S
    J Clin Pharm Ther; 1998 Oct; 23(5):399-401. PubMed ID: 9875690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednisone-induced worsening of neuromuscular function in myasthenia gravis.
    Miller RG; Milner-Brown HS; Mirka A
    Neurology; 1986 May; 36(5):729-32. PubMed ID: 3703276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dibutyryl cyclic AMP on neuromuscular transmission in myasthenia gravis.
    Hashimoto Y; Sasaki H; Iwatsuki K
    Tohoku J Exp Med; 1976 Oct; 120(2):197-8. PubMed ID: 185750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.